{"id":"https://openalex.org/W1999522127","doi":"https://doi.org/10.1097/jcp.0b013e31817ef470","title":"Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine Administration","display_name":"Physiological and Subjective Responses to Controlled Oral 3,4-Methylenedioxymethamphetamine Administration","publication_year":2008,"publication_date":"2008-08-01","ids":{"openalex":"https://openalex.org/W1999522127","doi":"https://doi.org/10.1097/jcp.0b013e31817ef470","mag":"1999522127","pmid":"https://pubmed.ncbi.nlm.nih.gov/18626271","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2587205"},"language":"en","primary_location":{"id":"doi:10.1097/jcp.0b013e31817ef470","doi":"https://doi.org/10.1097/jcp.0b013e31817ef470","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jcp.0b013e31817ef470","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2587205","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068960790","display_name":"Erin A Kolbrich","orcid":"https://orcid.org/0009-0002-3282-7988","observed_orcids":["https://orcid.org/0009-0002-3282-7988"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Erin A. Kolbrich","raw_affiliation_strings":["Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA","Chemistry and Drug Metabolism, \u2020Office of the Scientific Director, and \u2021Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]},{"raw_affiliation_string":"Chemistry and Drug Metabolism, \u2020Office of the Scientific Director, and \u2021Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008603341","display_name":"Robert S. Goodwin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert S. Goodwin","raw_affiliation_strings":["Chemistry and Drug Metabolism, \u2020Office of the Scientific Director, and \u2021Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry and Drug Metabolism, \u2020Office of the Scientific Director, and \u2021Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075445771","display_name":"David A. Gorelick","orcid":"https://orcid.org/0000-0003-1389-1394","observed_orcids":["https://orcid.org/0000-0003-1389-1394"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Gorelick","raw_affiliation_strings":["Office of the Scientific Director, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of the Scientific Director, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224 USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113508241","display_name":"Robert J. Hayes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J. Hayes","raw_affiliation_strings":["Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224 USA","National Institutes of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224 USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]},{"raw_affiliation_string":"National Institutes of Health","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023565994","display_name":"Elliot A. Stein","orcid":"https://orcid.org/0000-0003-0593-0269","observed_orcids":["https://orcid.org/0000-0003-0593-0269"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elliot A. Stein","raw_affiliation_strings":["Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224 USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000016116","display_name":"Marilyn Ann Huestis","orcid":"https://orcid.org/0000-0003-2137-4645","observed_orcids":["https://orcid.org/0000-0003-2137-4645"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I1327069482","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marilyn A. Huestis","raw_affiliation_strings":["Chemistry and Drug Metabolism, \u2020Office of the Scientific Director, and \u2021Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD","and reprint requests to Marilyn A. Huestis, PhD, Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Suite 5A72, Baltimore, MD 21224. E-mail: [email\u00a0protected]","reprint requests to Marilyn A. Huestis, PhD, Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Suite 5A72, Baltimore, MD 21224. E-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry and Drug Metabolism, \u2020Office of the Scientific Director, and \u2021Neuroimaging Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]},{"raw_affiliation_string":"and reprint requests to Marilyn A. Huestis, PhD, Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Suite 5A72, Baltimore, MD 21224. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]},{"raw_affiliation_string":"reprint requests to Marilyn A. Huestis, PhD, Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Biomedical Research Center, 251 Bayview Boulevard, Suite 5A72, Baltimore, MD 21224. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5000016116","https://openalex.org/A5008603341","https://openalex.org/A5068960790"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I1327069482"],"apc_list":null,"apc_paid":null,"fwci":10.3845,"has_fulltext":false,"cited_by_count":77,"citation_normalized_percentile":{"value":0.98199016,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"28","issue":"4","first_page":"432","last_page":"440"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T12553","display_name":"Psychedelics and Drug Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12649","display_name":"Alkaloids: synthesis and pharmacology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mdma","display_name":"MDMA","score":0.847000002861023},{"id":"https://openalex.org/keywords/ecstasy","display_name":"ecstasy","score":0.8080000281333923},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.574999988079071},{"id":"https://openalex.org/keywords/cardiovascular-effects","display_name":"cardiovascular effects","score":0.8320000171661377},{"id":"https://openalex.org/keywords/heart-rate","display_name":"heart rate","score":0.9700000286102295},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":1.0},{"id":"https://openalex.org/keywords/subjective-effects","display_name":"subjective effects","score":0.9319999814033508},{"id":"https://openalex.org/keywords/plasma-concentration","display_name":"plasma concentration","score":0.6100000143051147},{"id":"https://openalex.org/keywords/body-temperature","display_name":"body temperature","score":0.8550000190734863},{"id":"https://openalex.org/keywords/recreational-drug-use","display_name":"recreational drug use","score":0.8769999742507935}],"concepts":[{"id":"https://openalex.org/C2780876324","wikidata":"https://www.wikidata.org/wiki/Q69488","display_name":"MDMA","level":2,"score":0.9157301783561707},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.7513314485549927},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6295459866523743},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.60176682472229},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5836576223373413},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5748425722122192},{"id":"https://openalex.org/C2779488553","wikidata":"https://www.wikidata.org/wiki/Q625143","display_name":"Ecstasy","level":2,"score":0.5615661144256592},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5332861542701721},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5038110613822937},{"id":"https://openalex.org/C79410662","wikidata":"https://www.wikidata.org/wiki/Q1251001","display_name":"Dose\u2013response relationship","level":2,"score":0.46148768067359924},{"id":"https://openalex.org/C8213797","wikidata":"https://www.wikidata.org/wiki/Q754250","display_name":"Respiratory rate","level":4,"score":0.4341651499271393},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2831149101257324},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.18873077630996704},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001831","descriptor_name":"Body Temperature","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001831","descriptor_name":"Body Temperature","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002320","descriptor_name":"Cardiovascular Physiological Phenomena","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006213","descriptor_name":"Hallucinogens","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006213","descriptor_name":"Hallucinogens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006213","descriptor_name":"Hallucinogens","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007297","descriptor_name":"Inpatients","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010465","descriptor_name":"Perception","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018817","descriptor_name":"N-Methyl-3,4-methylenedioxyamphetamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018817","descriptor_name":"N-Methyl-3,4-methylenedioxyamphetamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018817","descriptor_name":"N-Methyl-3,4-methylenedioxyamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/jcp.0b013e31817ef470","doi":"https://doi.org/10.1097/jcp.0b013e31817ef470","is_oa":false,"landing_page_url":"https://doi.org/10.1097/jcp.0b013e31817ef470","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:18626271","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18626271","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2587205","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2587205","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Clin Psychopharmacol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2587205","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2587205","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Clin Psychopharmacol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G5631939526","display_name":"Neurobiology and Pharmacokinetics of Acute MDMA Administration","funder_award_id":"Z01DA000468","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G8443268838","display_name":null,"funder_award_id":"NIH0011996773","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W34984478","https://openalex.org/W36285515","https://openalex.org/W1905675815","https://openalex.org/W1973234849","https://openalex.org/W1973743872","https://openalex.org/W1974766709","https://openalex.org/W1992690798","https://openalex.org/W1994102540","https://openalex.org/W2002412029","https://openalex.org/W2002700337","https://openalex.org/W2011428797","https://openalex.org/W2017509011","https://openalex.org/W2018057120","https://openalex.org/W2022144436","https://openalex.org/W2024845040","https://openalex.org/W2025131082","https://openalex.org/W2035784753","https://openalex.org/W2036570302","https://openalex.org/W2038276801","https://openalex.org/W2042201688","https://openalex.org/W2070692593","https://openalex.org/W2075175363","https://openalex.org/W2082669257","https://openalex.org/W2085124531","https://openalex.org/W2091385849","https://openalex.org/W2098379364","https://openalex.org/W2107790349","https://openalex.org/W2119283923","https://openalex.org/W2121872553","https://openalex.org/W2122453635","https://openalex.org/W2124057719","https://openalex.org/W2131489415","https://openalex.org/W2146866952","https://openalex.org/W2158208927","https://openalex.org/W2162404750","https://openalex.org/W2162745202","https://openalex.org/W2164164342","https://openalex.org/W6601450858"],"related_works":["https://openalex.org/W1905675815","https://openalex.org/W7100891719","https://openalex.org/W2590375860","https://openalex.org/W2036570302","https://openalex.org/W2118539399","https://openalex.org/W2938925240","https://openalex.org/W2003616879","https://openalex.org/W2076933526","https://openalex.org/W2085124531","https://openalex.org/W2024845040"],"abstract_inverted_index":{"A":[0],"randomized,":[1],"within-subject,":[2],"double-blind,":[3],"inpatient":[4,42],"study":[5],"of":[6,12,34,83],"the":[7,81,195],"physiological":[8,176],"and":[9,29,57,112,120,133,177,191,220,233],"subjective":[10,121,178,221],"effects":[11,141,157,199,216,226],"oral":[13,35,208],"3,4-methylenedioxymethamphetamine":[14],"(MDMA)":[15],"was":[16],"conducted":[17],"in":[18,39,80,101,210],"human":[19],"volunteers":[20,62],"with":[21,149,183,231],"previous":[22],"MDMA":[23,36,184,209],"experience.":[24],"Placebo,":[25],"low":[26,190],"(1.0":[27],"mg/kg),":[28],"high":[30,134],"(1.6":[31],"mg/kg)":[32],"doses":[33,74,213],"were":[37,75,154,180,189],"administered":[38],"a":[40],"controlled":[41],"setting":[43],"at":[44,162],"least":[45],"7":[46],"days":[47],"apart":[48],"to":[49,77,127,144,197],"6":[50],"African":[51],"American":[52],"(4":[53],"male,":[54],"2":[55,58,145],"female)":[56],"white":[59],"(both":[60],"male)":[61],"(mean":[63],"[SE]":[64],"age,":[65],"21.1":[66],"[0.8]":[67],"years;":[68],"weight,":[69],"77.2":[70],"[7.7]":[71],"kg).":[72],"3,4-Methylenedioxymethamphetamine":[73,96],"46":[76],"150":[78],"mg,":[79],"range":[82],"typical":[84,211],"recreational":[85,212],"doses.":[86],"Participants":[87],"completed":[88],"all":[89],"sessions":[90],"without":[91],"clinically":[92,192],"significant":[93,98,156],"adverse":[94],"events.":[95],"produced":[97],"dose-dependent":[99],"increases":[100],"heart":[102],"rate":[103],"(highest,":[104,108,114],"132":[105],"bpm),":[106],"systolic":[107],"171":[109],"mm":[110,116],"Hg)":[111,117],"diastolic":[113],"102":[115],"blood":[118,168],"pressure,":[119],"responses":[122],"for":[123],"energy":[124],"level,":[125],"closeness":[126],"others,":[128],"mind":[129],"racing,":[130],"heightened":[131],"senses,":[132],"(evaluated":[135],"by":[136],"visual":[137],"analog":[138],"scales).":[139],"Peak":[140],"occurred":[142],"1":[143],"hours":[146],"after":[147],"dose,":[148],"no":[150,155],"secondary":[151],"peak.":[152],"There":[153],"on":[158,217],"body":[159],"temperature":[160,225],"(measured":[161],"tympanic":[163],"membrane),":[164],"respiratory":[165],"rate,":[166],"or":[167],"oxygen":[169],"saturation":[170],"(by":[171],"pulse":[172],"oximetry).":[173],"Although":[174],"most":[175],"parameters":[179],"significantly":[181],"correlated":[182],"plasma":[185,202],"concentrations,":[186],"correlation":[187],"coefficients":[188],"insignificant,":[193],"eliminating":[194],"ability":[196],"predict":[198],"from":[200,229],"single":[201],"concentrations.":[203],"These":[204],"findings":[205],"suggest":[206],"that":[207,224],"produces":[214],"short-term":[215],"cardiovascular":[218],"function":[219],"state":[222],"but":[223],"may":[227],"result":[228],"interaction":[230],"environmental":[232],"subject":[234],"factors.":[235]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}